Tuesday, June 23, 2020

Can't call Remdesiver, Favipiravir game changers in Covid-19 fight: Experts

Glenmark Pharmaceuticals has launched the antiviral drug Favipiravir, while Cipla and Hetero have received approvals from the Drug Controller General of India to launch Remdesivir

from Today's Paper https://ift.tt/2YnG13F
via

No comments:

Post a Comment

If you have any doubts please let me know!

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...